Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in rabbit aortic neointima after selective de-endothelialization

Atherosclerosis

Volumn 126, Issue 1, 1996, Pages 95-104

  Wang, He ^a   Moore, Sean ^a   Alavi, Misbahuddin Zafar ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Atherosclerosis; Extracellular matrix; Gene expression; In situ hybridization; Injury; RT PCR; TIMP

Indexed keywords

METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY WALL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE EXPRESSION; IMMUNOASSAY; IN SITU HYBRIDIZATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0030603981     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05898-4     Document Type: Article

References (45)

1. [1] Moore S, Alavi MZ. Vessel wall matrix: an overview. Proceedings of the 10th International Congress of Atherosclerosis. Editors: F.P. Woodford, J. Davignon and A. Sniderman, Elsevier: Amsterdam, 1995; 369.
2. [2] Li Z, Alavi MZ, Wasty F, Galis Z, Moore S. Proteoglycan synthesis by the neointimal smooth muscle cells cultured from rabbit aortic explants following de-endothelialization. Pathobiology 1993;61:89.
3. [3] Galis Z, Alavi MZ, Moore S. Co-localization of apolipoprotein B and chondroitin sulfate proteoglycans in an injury model of atherosclerosis. Am J Pathol 1993;142:1432.
4. [4] Camejo G, Fager G, Rosengren B, Hurt CE, Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells, J Biol Chem 1993; 268:14131.
5. [5] Libby P. Molecular bases of the acute coronary syndromes, Circulation 1995;91:2844.
6. [6] Woessner JF. The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11.
7. [7] Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and peridontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994;8:312.
8. [8] Krane SK. Clinical importance of metalloproteinases and their inhibitors. Ann NY Acad Sci 1994;732:1.
9. [9] Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris, TJR, Murphy G, Reynolds JJ. Sequence of human TIMP and its identity to erythroid-potentiating activity. Nature 1985;318:66.
10. [10] Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharma Ther 1993;59:329.
11. [11] Edwards DR, Rocheleau H, Sharma RR, Wills AJ, Cowie A, Hassell JA, Heath JK. Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 transcription. Biochim Biophys Acta 1992;117:41.
12. [12] Roswit WT, McCourt DW, Partridge NC, Jeffery JJ. Purification and sequence analysis of two rat tissue inhibitors of metalloproteinaess. Arch Biochem Biophys 1992;292:402.
13. [13] Smith GW, Goetz TL, Anthony RL, Smith MF. Molecular cloning of an ovine ovarian tissue inhibitor of metalloproteinases: ontogeny of messenger ribonucleic acid expression and in situ localization within pre-ovulatory follicles and luteal tissue. Endocrinology 1994;134:344.
14. [14] Yang TT, Hawkes SP. Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts. Proc Natl Acad Sci USA 1992;89:10676.
15. [15] Tilson MD, Reilly JM, Brophy CM, Webster EL, Barnett TR. Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 1993;18:266.
16. [16] Docherty AJP, Murphy G. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNA and recombinant proteins. Ann Rheum Dis 1990;49:469.
17. [17] Huebner K, Isobe M, Gasson JC, Golde DW, Croce CM. Localization of the gene encoding human erythroid-potentiating activity to chromosome region Xp11.1-Xp11.4. Am J Hum Genet 1986;38:819.
18. [18] Okada A, Gamier J-M, Vicarie S, Basset P. Cloning of the cDNA encoding rat tissue inhibitor of metalloproteinase-1, amino acid comparision with other TIMPs, and gene expression in rat tissues. Gene 1994;147:301.
19. [19] DeClerck YA. Purification and characterization of collagenase inhibitor produced by bovine vascular smooth muscle cells. Arch Biochem Biophys 1988;265:28.
20. [20] Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493.
21. [21] Alavi MZ, Moore S. Kinetics of low density lipoprotein interaction with rabbit aortic wall following balloon catheter de-endothelialization. Arteriosclerosis 1984;4:395.
22. [22] Chomcynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156.
23. [23] Bilder GE, Kasiewski CJ, Costello RJ, Hodge TG, Perrone MH. Electrode cuff-induced changes in DNA and PDGF gene expression in the rat carotid artery. Atherosclerosis 1993;100:103.
24. [24] Chomcynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and protein from cell and tissue samples. Biotechniques 1993;15:532.
25. [25] Galis ZS, Ghitescu LD, Li Z, Alavi MZ, Moore S. Distributation of endogenous apoprotein B-containing lipoproteins in normal and injured aortas of normocholesterolemic rabbits. Lab Invest 1992;66:624.
26. [26] Murphy G, Koklitis P, Carne AF. Dissociation of tissue inhibitor of metalloproteinases from enzyme complexes yields fully active inhibitor. Biochem J 1989;261:1031.
27. [27] O'Shea M, Willenbrock F, Williamson RA, Cockett MI, Freedman RB, Reynolds JJ, Docherty AJP, Murphy G. Site-directed mutation that alter the inhibitory activity of the tissue inhibitor of metalloproteinases-1: importance of the N-terminal region between cysteine 3 and cysteine 13. Biochemistry 1992;31:10146.
28. [28] Freudenstein J, Wagner S, Luck RM, Eispaniere R, Scheit, KH. mRNA of bovine tissue inhibitor of metalloproteinases: sequence and expression in bovine ovarian tissue. Biochem Biophys Res Commun 1990;171:250.
29. [29] Willenbrock F, Murphy G. Structure-function relationships in the tissue inhibitors of metalloproteinases. Am J Respir Crit Care Med 1994;150:S165.
30. [30] Horowitz S, Dafni N, Shapiro DL, Holm BA, Notter RH, Quille DJ. Hyperoxic exposure alters gene expression in the lung: induction of the tissue inhibitor of metalloproteinase mRNA and other mRNAs. J Biol Chem 1989;264:7092.
31. [31] Campbell CE, Flenniken AM, Skup D, William BRG. Identification of a serum and phorbol-ester responsive element in the murine tissue inhibitor of metalloproteinase gene. J Biol Chem 1991;266:7199.
32. [32] Leco KJ, Hayden LJ, Sharma RR, Rocheleau H, Greenberg AH, Edwards DR. Differentiatial regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras -transformed murine fibroblasts. Gene 1992;117:209.
33. [33] Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991;266:2017.
34. [34] Shapiro SD, Doyle GAR, Ley TJ, Parks WC, Welgus HG. Molecular mechanisms regulating the production of collagenase and tissue inhibitor of metalloproteinase in U937 cells: evidence for involvement of delayed transcritpional activation and enhanced mRNA stability. Biochemistry 1993;32:4286.
35. [35] Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res 1995;77:445.
36. [36] Kordula T, Guttgemann I, Rose-John S, Boeb E, Osthues A, Tschesche H, Koj A, Heinrich PC, Graeve L. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). FEBS Lett 1992;313:143.
37. [37] Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann NY Acad Sci 1994;748:501.
38. [38] Leco KJ, Khokha R, Pavloff N, Hawkes SP, Edwards DR. Tissue inhibtor of metalloproteinases-3 is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994;269:9352.
39. [39] Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner Jr. JF. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J CHn Invest 1989;84:678.
40. [40] Khokha R, Waterhouse P, Yagel S, Lala PK, Overall CM, Norton G, Denhardt DT. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989; 43:947.
41. [41] Lindsay CK, Thorgeirsson UP. Localization of messenger RNA for TIMP-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas. Clin Experimen Metast 1995;13:381.
42. [42] Stetler-Stevenson WG, Liotta LA, Kleiner Jr, DE. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993;7:1434.
43. [43] Zempo O, Kenagy RD, Au YPT, Bendeck M, Clowes MM, Reidy MA, Clowes AW. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg 1994;20:209.
44. [44] Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth promoting activity of tissue inhibitor of metalloproteinase-1 for a wide range of cells: a possible new growth factor in serum. FEBS Lett 1992;298:29.
45. [45] Stricklin GP, Nanney LB. Immunolocalization of collagenase and TIMP in healing human burn wounds. J Invest Dermatol 1994;103:488.